SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Stack David M – ‘3’ for 2/2/11 re: Pacira Pharmaceuticals, Inc.

On:  Wednesday, 2/2/11, at 6:01pm ET   ·   For:  2/2/11   ·   As:  Director and Officer   ·   Accession #:  1181431-11-6808   ·   File #:  1-35060

Previous ‘3’:  ‘3’ on / for 2/1/07   ·   Next:  ‘3’ on 12/12/12 for 12/10/12   ·   Latest:  ‘3’ on / for 7/15/15

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/02/11  Stack David M                     3          Dir.,Off.   2:11K  Pacira Pharmaceuticals, Inc.      R R Donnelley … Filer/FA

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of        HTML      8K 
                Securities by an Insider -- rrd299263.xml/2.3                    
 2: EX-24       Limited Power of Attorney for Section 16 Reporting  HTML      8K 
                Obligations

‘3’   —   Initial Statement of Beneficial Ownership of Securities by an Insider — rrd299263.xml/2.3



        

This ‘3’ Document is an XML Data File that may be rendered in various formats:

  Form 3    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Initial Statement of Beneficial Ownership of Securities by an Insider
 
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
STACK DAVID M
(Last)(First)(Middle)
C/O PACIRA PHARMACEUTICALS, INC.
10450 SCIENCE CENTER DRIVE
(Street)
SAN DIEGOCA92121
(City)(State)(Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
2/2/11		3. Issuer Name and Ticker or Trading Symbol
Pacira Pharmaceuticals, Inc. [ PCRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector 10% Owner
XOfficer (give title below) Other (specify below)
President and CEO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock18,600ISee Footnote (1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) (2) 9/2/20Common Stock185,9601.61D
Stock Option (Right to Buy) (3) 9/2/20Common Stock255,6951.61D
Stock Option (Right to Buy) (4) 12/29/20Common Stock158,4665.49D
Explanation of Responses:
(1)  The shares are held by Stack Schroon Mohawk FLP. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
(2)  The option vests as to 50% of the option shares on September 2, 2010 and, as to the remaining 50% of the option shares, in successive equal monthly installments for the subsequent 24 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering.
(3)  The option vests as to 25% of the option shares on September 2, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering.
(4)  The option vests as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering.
/s/ David Stack 2/2/11
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

↑Top
Filing Submission 0001181431-11-006808   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 1:43:53.2am ET